Skip to main content

stock

IONS · IONIS PHARMACEUTICALS INC

What IONIS PHARMACEUTICALS INC reports to the SEC, read from its filings.

Open in the app

Price

The live IONS price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on IONS.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
166,184,322 as of 2026-07-23 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-68.0%
Net
-64.7%

Returns

ROE
-128.5%
ROA
-18.9%

Health

Current ratio
7.9x
Debt/equity
—

Deep value

NCAV
-$63.49M
NCAV per share
-$0.38
Price/NCAV
Locked
NNWC
-$2.18B
NNWC per share
-$13.11
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$267.95M—Gross profit: unreported by this company.-$102.29M-$114.65M
10-Q filed 2026-07-29
2026-03-31$246.09M—Gross profit: unreported by this company.-$117.42M-$92.53M
10-Q filed 2026-04-29
2025-12-31$203.33M—Gross profit: unreported by this company.-$214.46M-$229.39M
10-K filed 2026-02-26
2025-09-30$156.72M—Gross profit: unreported by this company.-$160.18M-$128.61M
10-Q filed 2025-10-29
2025-06-30$452.05M—Gross profit: unreported by this company.$139.82M$123.55M
10-Q filed 2026-07-29
2025-03-31$131.61M—Gross profit: unreported by this company.-$146.86M-$146.94M
10-Q filed 2026-04-29
2024-12-31$226.58M—Gross profit: unreported by this company.-$110.82M-$104.35M
10-K filed 2026-02-26
2024-09-30$133.81M—Gross profit: unreported by this company.-$148.66M-$140.48M
10-Q filed 2025-10-29
Assets
$2.99B
Equity
$439.74M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$943.71M-$381.68M-$381.39M-$320.03M
2024-12-31$705.14M-$475.08M-$453.90M-$546.23M
2023-12-31$787.65M-$353.73M-$366.29M-$331.32M
2022-12-31$587.37M-$410.19M-$269.72M-$290.09M
2021-12-31$810.46M-$30.19M-$28.60M$18.84M
2020-12-31$729.26M-$172.08M-$444.26M$772,000
2019-12-31$1.12B$365.88M$278.14M$314.72M
2018-12-31$599.67M-$61.37M$273.74M$589.30M
2017-12-31$514.18M$31.05M$346,000$139.38M
2016-12-31$372.78M-$20.16M-$60.40M-$119.21M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

News

Stories that named IONS, and the market events around them.

Sign in to see this

Board

The IONS board could not be loaded.

Retry the IONS board

nakagai

Signals on IONS come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the IONS board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

IONIS PHARMACEUTICALS INC (IONS): SEC filings, financials and insider trades · Nakagai